No Data
No Data
Scotiabank Initiates CG Oncology(CGON.US) With Hold Rating, Announces Target Price $23
This UroGen Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Scotiabank Initiates CG Oncology at Sector Perform With $23 Price Target
Express News | CG Oncology Inc : Scotiabank Initiates Coverage With Sector Perform Rating; Target Price $23
LifeSci Capital Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $82
Buy Rating Affirmed for CG Oncology Amid Promising Trial Data and Market Opportunities